ArticleScientific reports2025

Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.

Shigeo Ohba et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.